Boston Scientific Corp.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | $4.20B | $6.54B | $217.0M |
| FY2014 | $4.20B | $6.46B | $587.0M |
| FY2015 | $5.65B | $6.32B | $319.0M |
| FY2016 | $5.42B | $6.73B | $196.0M |
| FY2017 | $3.82B | $7.01B | $188.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | $4.20B | $6.54B | $217.0M |
| FY2014 | $4.20B | $6.46B | $587.0M |
| FY2015 | $5.65B | $6.32B | $319.0M |
| FY2016 | $5.42B | $6.73B | $196.0M |
| FY2017 | $3.82B | $7.01B | $188.0M |